Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment. Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’.
Over 10 years after we first started supporting founders in bringing innovation and progress to healthcare, we are excited to unveil a refreshed brand identity for 7wire Ventures. With a new logo, website, and marketing collateral, we are changing the look of our brand but not our commitment to transforming healthcare.
Kili Preitauer is the CEO of Override Health, a platform bridging the gaps in traditional, fragmented pain care through virtual teams of chronic pain-trained physicians, physical therapists, coaches and behavioral health providers who individually treat chronic pain patients and collaborate to optimize patient outcomes.
As we move into 2025, the healthcare industry is positioned for even more significant change. The rapid growth of digital health solutions will continue to redefine care. With rising consumer demand for personalized, accessible treatments and new regulatory frameworks coming into play, we are entering an era where technology and healthcare are more intertwined than ever before. At 7wire Ventures, we see 2025 as a year of continued growth, with evolving opportunities across the sector.
2022 presented both familiar and novel challenges for the industry. Following a year of unprecedented funding, skyrocketing valuations, and a record number of IPOs, the digital health sector experienced a pullback amid shaky economic waters in 2022.
Embedded within the intricate framework of American healthcare, Medicaid is the country’s largest insurer, providing essential support to 28% of Americans (up from 18% in 2010). Its financial footprint drives 44% more expenditure than the commercial sector, amounting to $728B in annual health expenses.
We are pleased to announce that 7wireVentures has raised our latest investment vehicle, a $217M Growth & Opportunity Fund (GO Fund). The new capital will help our team support high-potential companies from our existing portfolio as they advance to later stages of funding, as well as to invest in other compelling Series B and C companies. The closing of our GO Fund brings the Firm’s AUM to over $500M.
David Schonthal has been an entrepreneur, investor, and innovation-leader in the healthcare world for over 20 years. He is an award-winning Professor of Strategy, Innovation & Entrepreneurship at the Kellogg School of Management and the author of the bestselling book, “The Human Element: Overcoming the Resistance That Awaits New Ideas”. In short, he is a man of many hats – all of which work to enrich and inform his role as Operating Partner at 7wireVentures.
Vivante Health, a digital digestive health solution that uniquely addresses the main challenges consumers with Gastrointestinal (GI) conditions face through personalized clinical care, announced a $31M equity financing Series B led by Mercato Partners.
Though there has been significant progress in advancing healthcare into the home, with a notable acceleration over the past few years driven by the COVID-19 pandemic, we are still very much in the starting blocks of the journey to make the home a true consumer-centered medical home.